Tirzepatide · For NASH and fatty liver disease

Tirzepatide for fatty liver (NASH/MASLD)

Your doctor mentioned fatty liver / elevated liver enzymes. Tirzepatide?

S-Tier Weight Loss RCT (late-stage)

New to peptides? Start with the foundations ->

Why people use Tirzepatide for NASH and fatty liver disease

Your doctor mentioned fatty liver / elevated liver enzymes. Tirzepatide? The short answer: yes, this is one of the more-discussed uses for Tirzepatide - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering Tirzepatide for NASH and fatty liver disease.

What the evidence says

Evidence tier: RCT (late-stage). Late-stage human trials are reporting; FDA review pending. Real evidence, near-final.

SYNERGY-NASH trial showed 62-74% NASH resolution at higher doses.
Fatty liver disease (NASH/MASLD) reversal is now a major Tirzepatide research front.
Likely future FDA indication for NASH treatment.

Protocol notes

Standard dosing. Hepatologist coordination if liver enzymes are significantly elevated.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

You start at 2.5mg once a week, then move up every four weeks until weight is coming off and side effects are tolerable. Most people land between 5mg and 15mg weekly. It is one shot a week, under the skin. Always with a doctor.

Typical starting dose: 2.5 mg subQ (under-the-skin shot) once weekly for the first 4 weeks. This is a starter dose - it is not meant to do real work, it is meant to wake your gut up gently.
Typical maintenance dose: Most users settle between 5 mg and 15 mg weekly. Many plateau at 7.5 to 10 mg. Higher dose is not always better - the gut side effects scale with the dose.
Frequency: Once weekly. Same day every week. Pick a day and stick with it.
Cycle length: Indefinite for chronic obesity or diabetes. Some users do 6 to 12 months for a defined weight-loss goal then taper.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full Tirzepatide directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine